Houlihan Lokey Advises BPD Healthcare

Houlihan Lokey is pleased to announce that BPD Healthcare (BPD), a portfolio company of WindRose Health Investors, has been acquired by MJH Life Sciences, a portfolio company of BDT & MSD Partners. Houlihan Lokey served as a financial advisor to BPD.

BPD, the leading tech-enabled comprehensive marketing and communications partner delivering transformational results to healthcare’s leading institutions, has joined forces with MJH Life Sciences, the largest privately held medical media company in North America.

BPD serves as a strategic growth partner to many of the nation’s leading health systems, academic medical centers, and healthcare innovators. The company partners with clients to provide fully integrated solutions—branding, marketing, communications, and business consulting—that are technology-enabled, AI-infused, and supported by a proprietary data platform. BPD helps healthcare stakeholders solve the C-Suite’s biggest challenges, including market assessments, patient acquisition, physician referrals, reputation management, payor negotiations, talent recruitment, and team engagement.

Together, MJH Life Sciences and BPD bring a powerful combination of reach, insight, and strategic capabilities to healthcare’s most trusted brands and stakeholders. MJH Life Sciences’ deep relationships with clinicians, researchers, and healthcare organizations complement BPD’s expertise in helping those organizations expand, engage, and evolve through the dynamic challenges impacting patient care. Combining BPD’s data-driven strategy and communications with MJH Life Sciences’ industry-leading healthcare content and engagement, the partnership creates a new model for how innovation moves through the healthcare system faster, smarter, and with greater impact for patients.

“Healthcare is changing faster than ever, and the organizations that thrive will be the ones that connect meaning with action,” said Jason Brown, CEO of BPD. “Joining MJH Life Sciences allows BPD to bring that connection to life on a much larger scale. Together, we can help our clients not just grow their brands but strengthen and innovate the industry to better care for patients and communities.”

The acquisition of BPD positions MJH Life Sciences to deliver an even more comprehensive suite of solutions that empower healthcare organizations to grow, innovate, and measure impact. This advances MJH Life Sciences’ long-standing commitment to improving patient care and outcomes through data-rich capabilities.

RELATED: Marketing Services, Mergers & Acquisitions